NL
STLN

NKCFO LLC’s Starling Oncology STLN Stock Holding History

NKCFO LLC’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-190,000
Closed -$663K – 118
2025
Q3 		$663K Buy
+190,000
New +$651K 0.2% 52

Other funds holding STLN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NKCFO LLC's STLN Position: Q4 2025 in Review

NKCFO LLC sold out of Starling Oncology (STLN) in Q4 2025, closing a stake of 190,000 shares — an estimated $663K sold.

NKCFO LLC first reported a position in STLN in Q3 2025 and held it in 1 quarter. The position peaked at $663K in Q3 2025. 117 funds tracked by Wall St. Rank hold STLN as of Q4 2025.

  • NKCFO LLC reported no remaining Starling Oncology position as of Q4 2025 after selling out during the quarter.
  • NKCFO LLC sold 190,000 Starling Oncology shares in Q4 2025, an estimated $663K.
  • NKCFO LLC first reported a position in Starling Oncology in Q3 2025 and held it in 1 quarter.
  • NKCFO LLC's Starling Oncology position peaked at $663K in Q3 2025.
  • 117 funds tracked by Wall St. Rank held Starling Oncology as of Q4 2025.

Based on NKCFO LLC's 13F filing for Q4 2025, filed 2 Feb 2026.